Joshua Ruch

Joshua Ruch

Co-Founder & Managing Partner

Featured
Joshua Ruch LinkedIn
 
“For 40 years, Rho has been investing across a broad array of sectors and stages. We’ve experienced many severe market cycles and have helped our companies successfully navigate the resulting turmult.”
— Joshua Ruch
 
 

Joshua Ruch is a Co-Founder and Managing Partner of Rho with more than 40 years of experience in venture capital. His investing philosophy is driven by a perspective that the human factor, common to all investment sectors, is the single most important determinant for successful investment outcomes. He most enjoys interacting with, supporting and mentoring his companies’ management teams.

His philanthropic activities include serving as a trustee of Mount Sinai Hospital Health Systems, Carnegie Hall and the National Humanities Center, and he is a member of the Board of Governors of the Technion and the Steering Committee of the Jacobs Institute.

He received an M.B.A. from the Harvard Business School.

  • CloudPay

    Fractal Systems

    Enerkem

    Nanit

  • Active Power (IPO)

    Capstone Turbine (IPO)

    Human Genome Sciences (IPO)

    MedImmune (IPO; acq. by AstraZeneca)

    Yantra (acq. by AT&T)

    3-D Pharmaceuticals (IPO; acq. by Johnson & Johnson)